---
title: "Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/605016.SH.md"
symbol: "605016.SH"
name: "Shandong Bailong Chuangyuan Bio-Tech Co., Ltd."
industry: "Packaged Foods and Meats"
datetime: "2026-05-21T17:39:32.628Z"
locales:
  - [en](https://longbridge.com/en/quote/605016.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/605016.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/605016.SH.md)
---

# Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SH)

## Company Overview

Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltitol, organic maltodextrin, allulose psicose, isomalt, and isomaltulose, as well as allulose powder and maltitol syrups.

| Item | Detail |
|------|--------|
| Industry | Packaged Foods and Meats |
| Exchange | CN Market |
| Website | [www.sdblcy.com](https://www.sdblcy.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:13.000Z

**Overall: B (0.28)**

**Industry**: Packaged Foods and Meats

| Metric | Value |
|--------|-------|
| Industry Ranking | 19 / 136 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 20.24% |  |
| Net Profit YoY | 49.09% |  |
| P/B Ratio | 5.54 |  |
| Dividend Ratio | 0.76% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 11502982139.72 |  |
| Revenue | 1455562671.30 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 21.22% | A |
| Profit Margin | 27.96% | A |
| Gross Margin | 45.11% | B |
| Revenue YoY | 20.24% | B |
| Net Profit YoY | 49.09% | B |
| Total Assets YoY | 28.55% | A |
| Net Assets YoY | 18.25% | A |
| Cash Flow Margin | 50.66% | C |
| OCF YoY | 20.24% | B |
| Turnover | 0.59 | B |
| Gearing Ratio | 25.63% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "20.24%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "49.09%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "5.54",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.76%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "11502982139.72",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1455562671.30",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "21.22%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "27.96%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "45.11%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "20.24%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "49.09%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "28.55%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "18.25%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "50.66%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "20.24%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.59",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "25.63%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 27.40 | 37/136 | 31.95 | 30.19 | 27.53 |
| PB | 5.37 | 118/136 | 5.52 | 4.97 | 4.67 |
| PS (TTM) | 7.66 | 131/136 | 7.97 | 7.15 | 6.73 |
| Dividend Yield | 0.78% | 79/136 | 0.87% | 0.83% | 0.72% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | HAI TIAN (603288.SH) | A | B | B | A | C | B |
| 02 | SHUANGHUI (000895.SZ) | B | C | A | C | C | B |
| 03 | HAID GROUP (002311.SZ) | B | C | A | C | B | B |
| 04 | YANGYUAN (603156.SH) | B | C | C | B | B | B |
| 05 | Wanchen Group (300972.SZ) | B | A | A | D | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-07T16:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 3 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 26.60 |
| Highest Target | 35.00 |
| Lowest Target | 29.90 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/605016.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/605016.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/605016.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/605016.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**